Africa Centres for Disease Control and Prevention

Last updated

The Africa Centres for Disease Control and Prevention (Africa CDC) is a public health agency of the African Union to support the public health initiatives of member states and strengthen the capacity of their health institutions to deal with disease threats. The Africa CDC ideas was proposed by the government of Ethiopia in 2013 during TB/HIV special submit in Abuja Nigeria. From 2013 to 2016 the modalities and statue of Africa CDC were developed and the specialized agency was officially launched in January 2017. [1]

Contents

History

The Africa CDC was established in January 2016 by the 26th Ordinary Assembly of Heads of State and Government to improve coordination among health institutions among African Union member states in dealing with disease threats. [1] African Union member states had first considered the idea of establishing a continent wide public health agency in 2013 at an AU Special Summit on HIV, Tuberculosis and Malaria in Abuja Nigeria (July 2013). The idea was proposed by the government of Ethiopia, then the Chair of the AU. The 2014 Ebola crisis accelerated the establishment of the Africa CDC, and also shaped perceptions of what its main purpose was to be and strengthened the importance of health emergency prevention and response. In July 2015, the African Union Ministers of Health meeting in Malabo had adopted the Statute of the Africa CDC, which called for fast-tracking the establishment of the institution. [2] The agency was officially launched in January 2017. [1] [3] [4]

2019–21 COVID-19 pandemic

The Africa CDC has played a role in responding to the global 2019–20 COVID-19 pandemic, which has affected Africa. In early April 2020, Director Dr John Nkengasong condemned remarks by two French scientists Professors Jean-Paul Mira and Camille Locht suggesting that a potential tuberculosis vaccine for the coronavirus be test in Africa as "disgusting and racist". Dr Mira has since apologized for his remarks. [5] [6] [7]

On 2 May 2020, the Africa CDC confirmed had nearly 40,000 cases, nearly 1,700 deaths, and more than 13,000 recoveries, and that COVID-19 had occurred in 53 African countries. [8] As of June 18, 2020, Africa CDC reported that 52 African Union Member States recorded a number of 267,519 cases, 7197 deaths, and 122,661 recoveries. [9] Egypt, Algeria, and South Africa were considered the countries with the highest risk to import the virus and with a moderate to high capability to block the virus outbreak. [9]

The Africa CDC has also worked with the Jack Ma Foundation to distribute COVID-19 testing kits throughout the continent. In 7 May, Dr Nkengasong disputed Tanzanian President John Magufuli's criticism that these tests were faulty and giving too many false positives. [10]

On 6 January 2021, the Africa CDC reported that the total number of cases in Africa has reached 2,854,971 while the death toll has reached 67,986 and that 2,361,900 have recovered. [11] On May 21, 2021, 55 member states of the African Union declared 4,732,150 cases, 127,612 deaths, and 4,238,275 recoveries. [12]

On 13 April 2021, the Partnership for African Vaccine Manufacturing was launched, aiming to increase vaccine production in Africa. Rwanda, Senegal, and South Africa were identified as countries where mRNA vaccines might be produced. Africa CDC aims to have 60% of vaccines used in Africa be produced in Africa by 2040, as opposed to less than 1% in 2021. [13]

Organizational structure

Africa-CDC-Direktor John Nkengasong (Kampala, 2016) Africa CDC Director Dr. John Nkengasong (37892303376).jpg
Africa-CDC-Direktor John Nkengasong (Kampala, 2016)

The Africa CDC is based at the Africa CDC Coordinating Centre in Addis Ababa, Ethiopia, which also contains the agency's Emergency Operations Centre. [3] [4] The agency is led by Director Dr John Nkengasong and Deputy Director Ahmed Ogwell Ouma. Besides its Executive Office and a Science and Programme Office, the agency also has several divisions dealing with "policy, health diplomacy, and communication," "management and administration," "surveillance and disease intelligence," "laboratory systems and networks," "emergency preparedness and response," and " public health institutes and research." [14]

The Africa CDC also has regional collaboration centres in Egypt, Nigeria, Gabon, Zambia and Kenya; which cover Northern Africa, Western Africa, Central Africa, Southern Africa, and Eastern Africa respectively. [3] [4] [15] The Africa CDC also runs a specialised Pathogen Genomics Intelligence Institute and an Institute for Workforce Development. [16]

See also

Related Research Articles

Centers for Disease Control and Prevention United States government public health agency

The Centers for Disease Control and Prevention (CDC) is the national public health agency of the United States. It is a United States federal agency, under the Department of Health and Human Services, and is headquartered in Atlanta, Georgia.

COVID-19 pandemic Ongoing global pandemic of coronavirus disease 2019

The COVID-19 pandemic, also known as the coronavirus pandemic, is an ongoing global pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The novel virus was first identified in the Chinese city of Wuhan in December 2019; a lockdown in Wuhan and other cities in surrounding Hubei failed to contain the outbreak, and it quickly spread to other parts of mainland China and around the world. The World Health Organization (WHO) declared a Public Health Emergency of International Concern on 30 January 2020, and a pandemic on 11 March 2020. Multiple variants of the virus have emerged and become dominant in many countries since 2021, with the Alpha, Beta, Gamma and Delta variants being the most virulent. As of 25 November 2021, more than 259 million cases and 5.17 million deaths have been confirmed, making the pandemic one of the deadliest in history.

COVID-19 pandemic by country and territory Data and maps, showing cases and deaths

This article provides a general overview and documents the status of locations affected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus which causes coronavirus disease 2019 (COVID-19) and is responsible for the COVID-19 pandemic. The first human cases of COVID-19 were identified in Wuhan, the capital of the province of Hubei in China in December 2019.

COVID-19 Contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Coronavirus disease 2019 (COVID-19) is a contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first known case was identified in Wuhan, China, in December 2019. The disease has since spread worldwide, leading to an ongoing pandemic.

COVID-19 pandemic in the United States Ongoing COVID-19 viral pandemic in the United States

The COVID-19 pandemic in the United States is part of the worldwide pandemic of coronavirus disease 2019. Since January 2020, 48,092,052 confirmed cases have been reported with 775,403 deaths, the most of any country, and the nineteenth-highest per capita worldwide. As many infections have gone undetected, the Centers for Disease Control and Prevention (CDC) estimated that, as of May 2021, there could be a total 120.2 million infections in the United States, or more than a third of the total population. COVID-19 is the deadliest pandemic in U.S. history; it was the third-leading cause of death in the U.S. in 2020, behind heart disease and cancer. From 2019 to 2020, U.S. life expectancy dropped by 3 years for Hispanic Americans, 2.9 years for African Americans, and 1.2 years for white Americans. These effects have persisted as U.S. deaths due to COVID-19 in 2021 exceeded those in 2020.

COVID-19 pandemic in Africa Ongoing COVID-19 viral pandemic in Africa

The COVID-19 pandemic was confirmed to have spread to Africa on 14 February 2020, with the first confirmed case announced in Egypt. The first confirmed case in sub-Saharan Africa was announced in Nigeria at the end of February 2020. Within three months, the virus had spread throughout the continent, as Lesotho, the last African sovereign state to have remained free of the virus, reported a case on 13 May 2020. By 26 May, it appeared that most African countries were experiencing community transmission, although testing capacity was limited. Most of the identified imported cases arrived from Europe and the United States rather than from China where the virus originated.

COVID-19 vaccine Vaccine designed to provide acquired immunity against SARS-CoV-2

A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2), the virus that causes coronavirus disease 2019 (COVID‑19). Prior to the COVID‑19 pandemic, an established body of knowledge existed about the structure and function of coronaviruses causing diseases like severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). This knowledge accelerated the development of various vaccine platforms during early 2020. The initial focus of SARS-CoV-2 vaccines was on preventing symptomatic, often severe illness. On 10 January 2020, the SARS-CoV-2 genetic sequence data was shared through GISAID, and by 19 March, the global pharmaceutical industry announced a major commitment to address COVID-19. The COVID‑19 vaccines are widely credited for their role in reducing the spread, severity, and death caused by COVID-19.

COVID-19 pandemic in Nigeria Ongoing COVID-19 viral pandemic in Nigeria

The COVID-19 pandemic in Nigeria is part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The first confirmed case in Nigeria was announced on 27 February 2020, when an Italian citizen in Lagos tested positive for the virus. On 9 March 2020, a second case of the virus was reported in Ewekoro, Ogun State, a Nigerian citizen who had contact with the Italian citizen.

COVID-19 pandemic in Sudan Ongoing COVID-19 viral pandemic in Sudan

The COVID-19 pandemic in Sudan is part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Sudan in March 2020.

The ongoing COVID-19 pandemic was confirmed to have spread to Libya on 24 March 2020, when the first case was officially confirmed in Tripoli.

The COVID-19 pandemic was confirmed to have reached Somalia on 16 March 2020 when the first case was confirmed in Mogadishu. The Somali Prime Minister, Hassan Ali Khaire announced that the government has set aside five million dollars to deal with the disease. The Somali Medical Association is concerned that the death toll in the country will be huge and that Somalia will not be able to recover from the economic effects due to poor working relations between central government and federal states which leads to lack of control by central government, as well and the lack of healthcare infrastructure. It has also been speculated that President Mohamed Abdullahi Mohamed may use the pandemic as an excuse to postpone elections. There have also been concerns over freedom of the press following arrests and intimidation of journalists who have been covering the pandemic in Somalia.

The COVID-19 pandemic in Madagascar is part of the ongoing worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. On 20 March 2020, the first case in Madagascar was confirmed in Antananarivo.

COVID-19 pandemic in Benin Ongoing COVID-19 viral pandemic in Benin

The COVID-19 pandemic in Benin is part of the ongoing worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Benin in March 2020.

The COVID-19 pandemic in Burundi is part of the ongoing worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Burundi on 25 March 2020.

The COVID-19 pandemic in Tanzania is part of the ongoing worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The COVID-19 pandemic was confirmed to have reached Tanzania in March 2020.

Moderna COVID-19 vaccine RNA COVID-19 vaccine

The Moderna COVID‑19 vaccine, codenamed mRNA-1273 and sold under the brand name Spikevax, is a COVID-19 vaccine developed by American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID) and the Biomedical Advanced Research and Development Authority (BARDA). It is authorized for use in people aged twelve years and older in some jurisdictions and for people eighteen years and older in other jurisdictions to provide protection against COVID-19 which is caused by infection by the SARS-CoV-2 virus. It is designed to be administered as two or three 0.5 mL doses given by intramuscular injection at an interval of at least 28 days apart.

John Nkengasong Cameroonian virologist, director of Africa CDC

John N. Nkengasong is a Cameroonian virologist and the Director of the Africa Centres for Disease Control and Prevention. He has previously worked at the World Health Organization (WHO) and Centers for Disease Control and Prevention. During the COVID-19 pandemic, Nkengasong was appointed the WHO Special Envoy for Africa.

Pfizer–BioNTech COVID-19 vaccine mRNA-based COVID-19 vaccine

The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech and for its development collaborated with American company Pfizer, for support with clinical trials, logistics, and manufacturing. It is authorized for use in people aged five years and older in some judrisdictions, twelve years and older in some jurisdictions, and for people sixteen years and older in other jurisdictions, to provide protection against COVID-19, caused by infection with the SARS-CoV-2 virus. The vaccine is given by intramuscular injection. It is composed of nucleoside-modified mRNA (modRNA) encoding a mutated form of the full-length spike protein of SARS-CoV-2, which is encapsulated in lipid nanoparticles. Initial advice indicated that vaccination required two doses given 21 days apart, but the interval was later extended to up to 42 days in the US, and up to four months in Canada.

Janssen COVID-19 vaccine Vaccine against COVID-19

The Janssen COVID-19 vaccine or Johnson & Johnson COVID-19 vaccine is a COVID-19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands, and its Belgian parent company Janssen Pharmaceuticals, subsidiary of American company Johnson & Johnson.

References

  1. 1 2 3 "About Us". Africa CDC. Archived from the original on 30 April 2020. Retrieved 9 May 2020.
  2. "Africa CDC Official Launch". African Union. 2017-01-31. Archived from the original on 30 June 2018. Retrieved 2020-04-13.
  3. 1 2 3 "The African Union launches Africa CDC, a Continent-wide Public Health Agency". Reliefweb . 2017-02-02. Archived from the original on 22 March 2020. Retrieved 2020-04-13.
  4. 1 2 3 "Africa CDC: Improving Disease Detection and Emergency Response on the African Continent". Centers for Disease Control and Prevention. 2017-07-27. Archived from the original on 22 March 2020. Retrieved 2020-04-13.
  5. "Statement of the Africa Centres for Disease Control and Prevention on the Potential Clinical Trial of a Tuberculosis Vaccine Protective Against COVID-19 in Africa". Africa Centers for Disease Control and Prevention. 9 April 2020. Archived from the original on 9 April 2020. Retrieved 9 April 2020.
  6. "French Doctor Apologises for Suggesting COVID-19 Treatment Be Tested in Africa". NY Times/Reuters. 3 April 2020. Archived from the original on 12 April 2020. Retrieved 13 April 2020.
  7. Mayberry, Kate; Siddiqui, Usaid; Najjar, Farah (9 April 2020). "Spain reports 683 coronavirus deaths in one day: Live updates". Al Jazeera . Archived from the original on 9 April 2020. Retrieved 9 April 2020.
  8. Qazi, Shereena; Varshalomidze, Tamila (2 May 2020). "Official says US missed chances to slow coronavirus: Live updates". Al Jazeera . Archived from the original on 3 May 2020. Retrieved 2 May 2020.
  9. 1 2 Staunton, Ciara; Swanepoel, Carmen; Labuschaigne, Melodie (July 25, 2020). "Between a rock and a hard place: COVID-19 and South Africa's response". Journal of Law and the Biosciences. Oxford University Press. 7 (1): 188–199. doi:10.1093/jlb/lsaa052. ISSN   2053-9711. OCLC   8662211992. PMC   7454702 . PMID   3290867.
  10. Rashid, Zaheena; Gadzo, Mersiha; Stepansky, Joseph (7 May 2020). "Coronavirus could kill 190,000 in Africa, WHO warns: Live updates". Al Jazeera . Archived from the original on 8 May 2020. Retrieved 7 May 2020.
  11. Wangpinghabtamu (6 January 2021). "Africa's confirmed COVID-19 cases pass 2.85 mln: Africa CDC". The Star . Archived from the original on 6 January 2021. Retrieved 6 January 2021.
  12. Africa CDC (May 21, 2021). "African Union Member States reporting COVID-19 cases". Africanews. Archived from the original on May 23, 2021. Retrieved May 28, 2021.
  13. Jerving, Sarah (14 April 2021). "AU launches Partnership for African Vaccine Manufacturing". Devex. Retrieved 25 June 2021.
  14. "Staff Directory". Africa CDC. Archived from the original on 25 April 2020. Retrieved 10 May 2020.
  15. "Regional Collaborating Centres". Africa CDC. Archived from the original on 25 April 2020. Retrieved 10 May 2020.
  16. "Africa CDC Institutes". Africa CDC. Archived from the original on 25 April 2020. Retrieved 10 May 2020.